期刊文献+

糖克宁对链脲佐菌素所致糖尿病大鼠降糖机理的研究 被引量:7

Mechanism of Tangkening in Reducing Blood Sugar in Rats with Diabetes Caused by Streptozotocin
下载PDF
导出
摘要 目的:观察中药糖克宁对糖尿病大鼠降糖作用和机理。方法:用STZ成功地制造了大鼠糖尿病模型,用中药糖克宁连续治疗8d。结果:STZ糖尿病大鼠的高血糖反应明显减轻,与模型组比较,差异有高度显著性,糖克宁组治疗后胰岛素和C肽水平有增高趋势。组织学研究提示糖克宁组大鼠胰腺组织中的胰岛数目较模型组增多,胰岛内细胞数亦相对增多,淋巴细胞浸润减少,炎症反应减轻。结论:糖克宁对糖尿病大鼠有较好的降糖作用,其作用机理可能是通过抵制或减轻自身免疫反应,减轻STZ对胰岛β细胞损伤,或促进已损伤的β细胞的修复,增强胰岛的分泌功能,从而减轻高血糖反应。此外还可能与益气养阴、活血化瘀类中药改善机体内环境,促进组织器官的血液循环。 OBJECTIVE:To observe the mechanism of Tangkening in reducing the blood sugar in rats with diabetes.METHOD:Rat diabetes models were made with STZ and were than treated with the Chinese drug Tangkening for 8 days.RESULT:The diabetic rats' blood sugar was reduced significantly as compared with the model group.The level of insulin and C peptide in the Tangkening Group increased.Histological researches indicated that in the Tangkening Group, the number of islets of Langerhans was greater than that in the model group,the number of cells in the islets of Langerhans increased,and there was a reduction in the infiltration of lymphocytes and inflammatory reaction.CONCLUSION:Tangkening has good effect in reducing blood sugar in rats and its mechanism lies in its funvitions to antagonize or relieve autoimmunity,reduce the damage of β cells caused by STZ,promote the repair of the damaged β cells and improve the secretion of the islets of Langerhans.The mechanism also has something to do with the functions of the drug to improve intemal environment,activate blood circulationr and enhance the sensitivity of insulin receptor in the tissue target cell.
出处 《南京中医药大学学报》 CAS CSCD 1999年第1期22-23,共2页 Journal of Nanjing University of Traditional Chinese Medicine
基金 江苏省科委科研基金
关键词 糖克宁 STZ 糖尿病 胰岛素 C肽 降糖机理 Tangkening,STZ diabetes rats,blood sugar,insulin,C peptide,mechanism in reducing blood sugar
  • 相关文献

参考文献3

  • 1陈奇.中药药理研究方法学[M].北京:人民卫生出版社,1994.362、757.
  • 2陈奇,中药药理研究方法学,1994年,815页
  • 3池芝盛,糖尿病学,1982年,155页

共引文献386

同被引文献50

  • 1宋福印,栗德林,周景华,王迎新,栗世铀,孙灵娇.消渴停对糖尿病大鼠胰岛B细胞凋亡影响的形态学观察[J].中国中医基础医学杂志,2000,6(8):21-24. 被引量:8
  • 2陈家伦.胰岛素抵抗与代谢病、心血管疾病[J].中华内分泌代谢杂志,1993,9(4):238-239. 被引量:44
  • 3于德民,吴锐,尹潍,袁咏.实验性链脲佐菌素糖尿病动物模型的研究[J].中国糖尿病杂志,1995,3(2):105-109. 被引量:425
  • 4覃洁萍 许学健 李健强 等.广西藤茶化学成分研究[J].天然产物开发与研究,1998,(1):20-20.
  • 5Lip - Gregory - YH, Alanna. Von Willebrand factor:a marker of endothelial dysfunction in vascular disorders[J ]. Cardiovascular Research, 1997, 34: 255 ~ 265
  • 6BlannAD, Taberner DA. A reliable marker of endothelial cell dysfunction: Does it exist [J ]. Br J Haematol, 1995, 90 (2):244~ 248
  • 7Papaccio G,Latronico M,Frascatore S,et al.Superoxide dimutase in low-dose-streptozotin-treatedmice,a dynamic time course study[J].Int J$Pancreatol,1991,10:253.
  • 8Maxwell SR,Thomason H,Sandler D,et al.Poor glycaemic control is associated with reduced serum radical scavenging(antioxidant)activity in non-insulin-dependent diabetes mellitus[J].Ann Clin Biochem,1997,34(6):638.
  • 9Blann AD,Taberner DA.A reliable marker of endothelial cell dysfunction:Does it exits[J].Br J Haematol,1995:90(2):224-248
  • 10Lip GY,Blann A.von Willebrand factor:a marker of endothelial dysfunction in vascular disorders[J].Gardiovasc Res,1997,34(2):255-265

引证文献7

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部